Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
Rota
Eugenia
E
Neurology Unit, S. Croce Hospital, Mondovì (CN), Italy. eugenia_rota@yahoo.it
Bazzan
Mario
M
Fantino
Giovanni
G
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects; D005260:Female; D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D010976:Platelet Count; D011134:Polysaccharides / Q000009:adverse effects*; D012008:Recurrence; D012449:Safety; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*; D020246:Venous Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D000077425:Fondaparinux